Reviewed by Megan Craig, M.Sc. Rapid Novor Inc., the world’s leader in mass spectrometry (MS)-based antibody protein sequencing, announced today that its REpAb® antibody discovery platform was used to successfully sequence a complex mixture of functional antibodies directly from the serum of a human patient after receiving a COVID-19 vaccine. Image Credit: Rapid Novor Inc. This demonstrates...
by Win Reynolds, Northwestern University Credit: CC0 Public Domain Scientists at Northwestern Medicine are using new advances in CRISPR gene-editing technology to uncover new biology that could lead to longer-lasting treatments and new therapeutic strategies for Human Immunodeficiency Virus (HIV). The HIV epidemic has been overlooked during the COVID-19 pandemic but represents a critical and...
